BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 19172830)

  • 1. [Role of c-c chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of C-C chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Pneumonol Alergol Pol; 2008; 76(6):415-20. PubMed ID: 19173189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [VEGF (vascular endothelial growth factor) concentration in serum and pleural fluid of patients with pleural malignancy and pleural tuberculosis].
    Ziora D; Sielska-Spytek E; Dworniczak S; Oklek K; Kozielski J
    Pneumonol Alergol Pol; 2002; 70(9-10):458-67. PubMed ID: 12710098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
    Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cholinesterase to differentiate pleural exudates and transudates.
    Sharma M; Gupta KB; Goyal KM; Nand N
    J Assoc Physicians India; 2004 May; 52():387-90. PubMed ID: 15656028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
    Castaño Vidriales JL; Amores Antequera C
    Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
    Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions.
    Economidou F; Antoniou KM; Tzanakis N; Sfiridaki K; Siafakas NM; Schiza SE
    Respir Med; 2008 May; 102(5):774-9. PubMed ID: 18304793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions.
    Shu J; Sun G; Liu H; Liu J
    Acta Oncol; 2007; 46(7):1004-11. PubMed ID: 17917830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnosis between exudate and transudate in pleural effusion].
    Vázquez F; Michelángelo H; Trevisani H; González F; de Quiros B
    Medicina (B Aires); 1996; 56(3):223-30. PubMed ID: 9035477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pleural viscosity in the differential diagnosis of exudative pleural effusion.
    Yetkin O; Tek I; Yetkin F; Numanoglu N
    Respirology; 2007 Mar; 12(2):267-71. PubMed ID: 17298461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of vascular endothelial growth factor (VEGF) in neoplastic and tuberculosis effusions--preliminary results].
    Jankowska R; Porebska I; Dyła T
    Pneumonol Alergol Pol; 2002; 70(5-6):258-64. PubMed ID: 12518624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
    Zhou WB; Bai M; Jin Y
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
    Bishara J; Goldberg E; Ashkenazi S; Yuhas Y; Samra Z; Saute M; Shaked H
    Ann Thorac Surg; 2009 Jan; 87(1):251-4. PubMed ID: 19101307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions.
    Han CH; Choi JE; Chung JH
    Intern Med; 2008; 47(19):1669-74. PubMed ID: 18827414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of soluble B7-H4 in malignant pleural effusion].
    Xu CH; Yu LK
    Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):117-8. PubMed ID: 22490695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion.
    Chan MC; Chang KM; Chao WC; Lin LY; Kuo BI; Hsu JY; Wu CL
    Respirology; 2007 May; 12(3):333-8. PubMed ID: 17539835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural adenosine deaminase in the separation of transudative and exudative pleural effusions.
    Atalay F; Ernam D; Hasanoglu HC; Karalezli A; Kaplan O
    Clin Biochem; 2005 Dec; 38(12):1066-70. PubMed ID: 16226239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.